Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Dutka

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Clinical Medicine (London, England)|May 16, 2008
Non-invasive cardiac imagingDavid P Dutka
Expert Review of Cardiovascular Therapy|May 28, 2011
Does remote ischemic conditioning salvage left ventricular function after successful primary PCI?Stephen P Hoole, David P Dutka
Current Heart Failure Reports|June 3, 2009
Insulin resistance and heart failurePatrick M Heck, David P Dutka
Current Opinion in Supportive and Palliative Care|December 9, 2008
A systematic approach to refractory anginaSadia N Khan, David P Dutka
Heart Failure Reviews|May 27, 2003
Hibernation and congestive heart failureDavid P Dutka, Paolo G Camici
Cardiovascular & Hematological Agents in Medicinal Chemistry|July 26, 2012
Cardiac protection via metabolic modulation: an emerging role for incretin-based therapies?Liam M McCormick, Anna C Kydd, David P Dutka
Expert Review of Medical Devices|November 3, 2012
Optimizing benefit from CRT: role of speckle tracking echocardiography, the importance of LV lead position and scarAnna C Kydd, Liam M McCormick, David P Dutka
Cardiovascular Diabetology|January 14, 2014
Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1Sophie J Clarke, Liam M McCormick, David P Dutka
Heart (British Cardiac Society)|May 13, 2011
Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery diseasePhilip A Read, Fakhar Z Khan, David P Dutka
Cardiovascular Diabetology|June 26, 2010
Hyperinsulinemia improves ischemic LV function in insulin resistant subjectsPatrick M Heck, Stephen P Hoole, Sadia N Khan, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Clinical Medicine (London, England)|May 16, 2008
Non-invasive cardiac imagingDavid P Dutka
Expert Review of Cardiovascular Therapy|May 28, 2011
Does remote ischemic conditioning salvage left ventricular function after successful primary PCI?Stephen P Hoole, David P Dutka
Current Heart Failure Reports|June 3, 2009
Insulin resistance and heart failurePatrick M Heck, David P Dutka
Current Opinion in Supportive and Palliative Care|December 9, 2008
A systematic approach to refractory anginaSadia N Khan, David P Dutka
Heart Failure Reviews|May 27, 2003
Hibernation and congestive heart failureDavid P Dutka, Paolo G Camici
Cardiovascular & Hematological Agents in Medicinal Chemistry|July 26, 2012
Cardiac protection via metabolic modulation: an emerging role for incretin-based therapies?Liam M McCormick, Anna C Kydd, David P Dutka
Expert Review of Medical Devices|November 3, 2012
Optimizing benefit from CRT: role of speckle tracking echocardiography, the importance of LV lead position and scarAnna C Kydd, Liam M McCormick, David P Dutka
Cardiovascular Diabetology|January 14, 2014
Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1Sophie J Clarke, Liam M McCormick, David P Dutka
Heart (British Cardiac Society)|May 13, 2011
Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery diseasePhilip A Read, Fakhar Z Khan, David P Dutka
Cardiovascular Diabetology|June 26, 2010
Hyperinsulinemia improves ischemic LV function in insulin resistant subjectsPatrick M Heck, Stephen P Hoole, Sadia N Khan, et al.
Pageof 6